Skip to Contents

Meet Us at ISMB/ECCB 2025

Meet Us at ISMB/ECCB 2025.

Investigating the Mechanisms of HM17321-Induced Fat loss and Lean Mass Preservation for Clinical Application
Poster Number
B-447
Session
Session B, Jul 22 at 10:00~11:20 AM and 16:00~16:40 PM
Presenter
Seunghwan Jung, Ph.D /
Hanmi Pharmaceutical

Hanmi's New Story

Creativity, Innovation, and Challenge
A New Era Takes Off at Hanmi

Latest News

Hanmi’s Next-Generation EZH1/2 Dual Inhibitor Demonstrates Potential to Overcome Resistance Mechanisms

2025.07.04

Dr. Young Su Noh presents the latest research findings on HM97662 at ICML 2025.jpg Dr. Young Su Noh presents the latest research findings on HM97662 at ICML 2025.jpg
Hanmi’s Next-Gen Obesity Drug Gains Momentum: Nearly 5% Weight Loss After 4 Weeks, Up to 10% in Individual Case

2025.06.27

Researchers from Hanmi R&D Center Presenting at ADA 2025.jpg Researchers from Hanmi R&D Center Presenting at ADA 2025.jpg
Pushing the Boundaries of GLP-1 Innovation ― Hanmi to Present Six Obesity Drug Studies at ADA 2025

2025.06.10

Overview of key poster abstracts Hanmi will present at ADA 2025.png Overview of key poster abstracts Hanmi will present at ADA 2025.png
View More

Focus on Making
Innovative Medicines

Hanmi Pharmaceutical is leading innovation in the
pharmaceutical industry with a sustainable R&D
infrastructure covering various therapeutic areas.

Obesity/Metabolism

Developing best-in-class drugs for obesity,
non-alcoholic steatohepatitis,
and more with multiple mechanisms of action

View More

CDMO

Bio

We have global competitiveness in the manufacturing and developing of biopharmaceuticals such as recombinant proteins based on microbial culture and biochemical reaction processes.

Fine Chemical

Based on our diverse API experience, Hanmi Fine Chemical is focusing on challenging CDMO businesses such as complicated peptides, PEG, and NTP.

Chemical

The cutting-edge ICT-based Paltan Smart Plant, with an annual production capacity of over 6 billion tablets, supplies the world with high-quality synthetic medicines optimized to global standards.

ESG Report

Hanmi ESG is Everyday-life Innovation

View More

Your dream is our future.
Hanmi awaits you.

Join Us